Bacillus subtilis M406 and application thereof to preparation of bacteriocin and cellulase

The invention discloses Bacillus subtilis M406 and an application thereof to preparation of bacteriocin and cellulase. The Bacillus subtilis M406 strain is preserved with the number of CCTCC NO:M 2018234. One probiotic strain, namely, the Bacillus subtilis M406 is screened out on the basis of the th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: NIU YAORONG, WANG XINKAI, HU JUN, HOU QILIANG, YAN XIANGHUA
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator NIU YAORONG
WANG XINKAI
HU JUN
HOU QILIANG
YAN XIANGHUA
description The invention discloses Bacillus subtilis M406 and an application thereof to preparation of bacteriocin and cellulase. The Bacillus subtilis M406 strain is preserved with the number of CCTCC NO:M 2018234. One probiotic strain, namely, the Bacillus subtilis M406 is screened out on the basis of the thought of taking one character as main and various characters as auxiliaries, and use value of probiotic is increased. Antibacterial active substances which can be produced by the Bacillus subtilis M406 can inhibit various harmful bacteria including S. typhimurium, Salmonella enteritidis, S.aureus, E.coli and Listeria monocytogenes in animal intestines. The probiotic can ferment multiple saccharides for acid production, and pH of intestinal juice is reduced. The Bacillus subtilis M406 produces cellulase, so that structural carbohydrates in coarse fodder can be degraded effectively, part of NSP can be transformed into soluble saccharides, fats, proteins and amino acids, and nutritional value of the coarse fodder is i
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN109161498A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN109161498A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN109161498A3</originalsourceid><addsrcrecordid>eNqNjDEKwkAQRdNYiHqH8QBCFkMwpQbFRisrmzBZJ2Rg2B12Nvc3qAewevB4_y-L5wk9i0wGNvWZhQ1uVVkDhhegqrDHzDFAHilRHCBH0ESK6atn06PPlDh6Dp-Vp_lO0GhdLAYUo82Pq2J7OT_a6440dmSKngLlrr27snG1q5rDcf9P8wbgiDq1</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Bacillus subtilis M406 and application thereof to preparation of bacteriocin and cellulase</title><source>esp@cenet</source><creator>NIU YAORONG ; WANG XINKAI ; HU JUN ; HOU QILIANG ; YAN XIANGHUA</creator><creatorcontrib>NIU YAORONG ; WANG XINKAI ; HU JUN ; HOU QILIANG ; YAN XIANGHUA</creatorcontrib><description>The invention discloses Bacillus subtilis M406 and an application thereof to preparation of bacteriocin and cellulase. The Bacillus subtilis M406 strain is preserved with the number of CCTCC NO:M 2018234. One probiotic strain, namely, the Bacillus subtilis M406 is screened out on the basis of the thought of taking one character as main and various characters as auxiliaries, and use value of probiotic is increased. Antibacterial active substances which can be produced by the Bacillus subtilis M406 can inhibit various harmful bacteria including S. typhimurium, Salmonella enteritidis, S.aureus, E.coli and Listeria monocytogenes in animal intestines. The probiotic can ferment multiple saccharides for acid production, and pH of intestinal juice is reduced. The Bacillus subtilis M406 produces cellulase, so that structural carbohydrates in coarse fodder can be degraded effectively, part of NSP can be transformed into soluble saccharides, fats, proteins and amino acids, and nutritional value of the coarse fodder is i</description><language>chi ; eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROCESSES USING MICROORGANISMS ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190108&amp;DB=EPODOC&amp;CC=CN&amp;NR=109161498A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,782,887,25573,76557</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190108&amp;DB=EPODOC&amp;CC=CN&amp;NR=109161498A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>NIU YAORONG</creatorcontrib><creatorcontrib>WANG XINKAI</creatorcontrib><creatorcontrib>HU JUN</creatorcontrib><creatorcontrib>HOU QILIANG</creatorcontrib><creatorcontrib>YAN XIANGHUA</creatorcontrib><title>Bacillus subtilis M406 and application thereof to preparation of bacteriocin and cellulase</title><description>The invention discloses Bacillus subtilis M406 and an application thereof to preparation of bacteriocin and cellulase. The Bacillus subtilis M406 strain is preserved with the number of CCTCC NO:M 2018234. One probiotic strain, namely, the Bacillus subtilis M406 is screened out on the basis of the thought of taking one character as main and various characters as auxiliaries, and use value of probiotic is increased. Antibacterial active substances which can be produced by the Bacillus subtilis M406 can inhibit various harmful bacteria including S. typhimurium, Salmonella enteritidis, S.aureus, E.coli and Listeria monocytogenes in animal intestines. The probiotic can ferment multiple saccharides for acid production, and pH of intestinal juice is reduced. The Bacillus subtilis M406 produces cellulase, so that structural carbohydrates in coarse fodder can be degraded effectively, part of NSP can be transformed into soluble saccharides, fats, proteins and amino acids, and nutritional value of the coarse fodder is i</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROCESSES USING MICROORGANISMS</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjDEKwkAQRdNYiHqH8QBCFkMwpQbFRisrmzBZJ2Rg2B12Nvc3qAewevB4_y-L5wk9i0wGNvWZhQ1uVVkDhhegqrDHzDFAHilRHCBH0ESK6atn06PPlDh6Dp-Vp_lO0GhdLAYUo82Pq2J7OT_a6440dmSKngLlrr27snG1q5rDcf9P8wbgiDq1</recordid><startdate>20190108</startdate><enddate>20190108</enddate><creator>NIU YAORONG</creator><creator>WANG XINKAI</creator><creator>HU JUN</creator><creator>HOU QILIANG</creator><creator>YAN XIANGHUA</creator><scope>EVB</scope></search><sort><creationdate>20190108</creationdate><title>Bacillus subtilis M406 and application thereof to preparation of bacteriocin and cellulase</title><author>NIU YAORONG ; WANG XINKAI ; HU JUN ; HOU QILIANG ; YAN XIANGHUA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN109161498A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2019</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROCESSES USING MICROORGANISMS</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>NIU YAORONG</creatorcontrib><creatorcontrib>WANG XINKAI</creatorcontrib><creatorcontrib>HU JUN</creatorcontrib><creatorcontrib>HOU QILIANG</creatorcontrib><creatorcontrib>YAN XIANGHUA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>NIU YAORONG</au><au>WANG XINKAI</au><au>HU JUN</au><au>HOU QILIANG</au><au>YAN XIANGHUA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Bacillus subtilis M406 and application thereof to preparation of bacteriocin and cellulase</title><date>2019-01-08</date><risdate>2019</risdate><abstract>The invention discloses Bacillus subtilis M406 and an application thereof to preparation of bacteriocin and cellulase. The Bacillus subtilis M406 strain is preserved with the number of CCTCC NO:M 2018234. One probiotic strain, namely, the Bacillus subtilis M406 is screened out on the basis of the thought of taking one character as main and various characters as auxiliaries, and use value of probiotic is increased. Antibacterial active substances which can be produced by the Bacillus subtilis M406 can inhibit various harmful bacteria including S. typhimurium, Salmonella enteritidis, S.aureus, E.coli and Listeria monocytogenes in animal intestines. The probiotic can ferment multiple saccharides for acid production, and pH of intestinal juice is reduced. The Bacillus subtilis M406 produces cellulase, so that structural carbohydrates in coarse fodder can be degraded effectively, part of NSP can be transformed into soluble saccharides, fats, proteins and amino acids, and nutritional value of the coarse fodder is i</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN109161498A
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROCESSES USING MICROORGANISMS
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
title Bacillus subtilis M406 and application thereof to preparation of bacteriocin and cellulase
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-02T23%3A36%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=NIU%20YAORONG&rft.date=2019-01-08&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN109161498A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true